EGEE Industry Day

The Finnish Centre for ScienceThe fifth EGEE Industry Day - Biomedical Challenges in Grid Adoption between Research and Industry - takes place on 24 November 2006 in Helsinki, Finland. It is kindly hosted by the Finnish IT Centre for science.

The Finnish Centre for Science (CSC) in Helsinki, Finland, will provide the perfect backdrop to discuss how the pharmaceutical sector is, today, a natural adopter of Grid technologies. Distributed computing infrastructures enable a more seamless collaboration in terms of analysis activities and the product design process. By embracing these new technologies, Bio-informatics research centres and ultimately pharmaceutical companies will be able to bring products to market faster, with better quality and efficiency, thus gaining a competitive edge in the marketplace and increasing revenue. These are all key business drivers not only for pharmaceutical companies but also for businesses operating in a broad spectrum of sectors.

The 5th EGEE Industry Day is devoted to exploring these issues, offering insight into new solutions aimed at enabling biological and medical problem-solving. This event will offer a forum for interaction with EGEE Management, developers of the EGEE Grid infrastructure and experts in Bio-Informatics. Business players and research organisations will learn about the EGEE framework through which they can confidently move forward with the adoption of its Grid technologies.

The agenda includes case studies and real-life scenarios, with presentations exploring current and future developments of the EGEE Grid infrastructure, as well as Scandinavian and European perspectives and the potential for collaboration in this domain. In addition, participants will have the opportunity to find out about Bio-informatics services, one of CSC's core areas, built on the most powerful computing and network infrastructures in the Nordic countries.

For further information, please visit:
http://www.eu-egee.org/contents/egee_events/industryday/
IndustryDay_Finland_Helsinki

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...